Results 11 to 20 of about 9,021,994 (240)

Update on rabies

open access: yesResearch and Reports in Tropical Medicine, 2011
Alan C JacksonDepartments of Internal Medicine (Neurology) and Medical Microbiology, University of Manitoba, Winnipeg, MB, CanadaAbstract: Human rabies is almost invariably fatal, and globally it remains an important public health problem.
Alan C Jackson
doaj   +1 more source

Human Rabies - Texas, 2021. [PDF]

open access: yesMMWR Morb Mortal Wkly Rep, 2022
In late August 2021, a boy aged 7 years was bitten by a bat while he was playing outside his apartment home in Medina County, Texas. He informed his parents; however, no rabies postexposure prophylaxis (PEP) was sought because there were no visible bite marks, and the family was unaware that contact with a bat, including in the absence of visible bite ...
Blackburn D   +17 more
europepmc   +4 more sources

Hydrophobia of human rabies [PDF]

open access: yesClinical Case Reports, 2018
Key Clinical Message Hydrophobia is a clinical sign characteristic of human rabies. This sign occurs following paroxysmal contractions of pharynx responsible for hydrophobic spasms.
Juliana R. Tongavelona   +2 more
openaire   +3 more sources

Renewed global partnerships and redesigned roadmaps for rabies prevention and control [PDF]

open access: yes, 2011
Canine rabies, responsible for most human rabies deaths, is a serious global public health concern. This zoonosis is entirely preventable, but by focusing solely upon rabies prevention in humans, this "incurable wound" persists at high costs.
Wandeler, Alexander   +63 more
core   +1 more source

Evidence-based control of canine rabies: a critical review of population density reduction [PDF]

open access: yes, 2013
Control measures for canine rabies include vaccination and reducing population density through culling or sterilization. Despite the evidence that culling fails to control canine rabies, efforts to reduce canine population density continue in many parts
Boots, M.   +6 more
core   +2 more sources

Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans [PDF]

open access: yes, 2013
Rabies kills many people throughout the developing world every year. The murine monoclonal antibody (mAb) 62-71-3 was recently identified for its potential application in rabies postexposure prophylaxis (PEP).
Both, L   +26 more
core   +1 more source

Europe's contribution to the evaluation of the use of systemic antimicrobials in the treatment of periodontitis

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract This narrative review celebrates Europe's contribution to the current knowledge on systemically administered antimicrobials in periodontal treatment. Periodontitis is the most frequent chronic noncommunicable human disease. It is caused by dysbiotic bacterial biofilms and is commonly treated with subgingival instrumentation.
David Herrera   +4 more
wiley   +1 more source

Emerging Technologies for the Detection of Rabies Virus: Challenges and Hopes in the 21st Century [PDF]

open access: yes, 2009
The diagnosis of rabies is routinely based on clinical and epidemiological information, especially when exposures are reported in rabies-endemic countries.
Müller, Thomas   +34 more
core   +1 more source

Estimating the global burden of endemic canine rabies [PDF]

open access: yes, 2015
Rabies is a notoriously underreported and neglected disease of low-income countries. This study aims to estimate the public health and economic burden of rabies circulating in domestic dog populations, globally and on a country-by-country basis, allowing
Schumacher, Carolin   +140 more
core   +1 more source

Estimating the public health impact of rabies. [PDF]

open access: yes, 2004
Rabies is a fatal, preventable zoonosis, but it is not effectively controlled throughout much of the developing world. The impetus for control is hampered by a lack of awareness of its true impact. We estimate a disability-adjusted life year (DALY) score
Coleman, Paul G   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy